Letter to the editor regarding "Kılıçarslan A, Kurt Çevik G, Doğan M, Aksoy Altınboğa A, Ceran F, et al. Does CD47 expression have prognostic significance in classical Hodgkin lymphoma? Turkish Journal of Medical Sciences: 2025; 55 (1): 22".
作者信息
Baba Burcu, Akbay Ayşegül
机构信息
Department of Medical Biochemistry, Faculty of Medicine, Yüksek İhtisas University, Ankara, Turkiye.
出版信息
Turk J Med Sci. 2025 May 4;55(4):1035-1036. doi: 10.55730/1300-0144.6056. eCollection 2025.
Abstract
摘要
相似文献
1
Letter to the editor regarding "Kılıçarslan A, Kurt Çevik G, Doğan M, Aksoy Altınboğa A, Ceran F, et al. Does CD47 expression have prognostic significance in classical Hodgkin lymphoma? Turkish Journal of Medical Sciences: 2025; 55 (1): 22".致编辑的信，关于“基利恰尔斯兰A、库尔特·切维克G、多安M、阿克索伊·阿尔廷博阿A、塞兰F等人。CD47表达在经典型霍奇金淋巴瘤中是否具有预后意义？《土耳其医学科学杂志》：2025年；55（1）：22”
Turk J Med Sci. 2025 May 4;55(4):1035-1036. doi: 10.55730/1300-0144.6056. eCollection 2025.
2
Does CD47 expression have prognostic significance in classical Hodgkin lymphoma?CD47表达在经典型霍奇金淋巴瘤中是否具有预后意义？
Turk J Med Sci. 2024 Dec 30;55(1):203-208. doi: 10.55730/1300-0144.5958. eCollection 2025.
3
RETRACTION: The Role of Orthobiologics in Chronic Wound Healing.撤回声明：骨科生物制剂在慢性伤口愈合中的作用。
Int Wound J. 2025 Aug;22(8):e70744. doi: 10.1111/iwj.70744.
4
Is GATA3 Useful for Differentiating between Classical Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin lymphoma? A Two-Center Study in Tehran, Iran during 2016 to 2022.GATA3对鉴别经典型霍奇金淋巴瘤和结节性淋巴细胞为主型霍奇金淋巴瘤是否有用？2016年至2022年在伊朗德黑兰进行的一项双中心研究。
Asian Pac J Cancer Prev. 2025 Apr 1;26(4):1421-1427. doi: 10.31557/APJCP.2025.26.4.1421.
5
Trained ILCs confer adaptive immunity-independent protection against influenza.经过训练的固有淋巴细胞可提供独立于适应性免疫的流感防护。
J Virol. 2025 Aug 4:e0053225. doi: 10.1128/jvi.00532-25.
6
species on palms - integrative taxonomic approach for species boundaries delimitation in the genus , with the description of .棕榈树上的物种——该属物种界限划分的综合分类学方法，以及对……的描述 。 （原文中“with the description of.”后面内容缺失，翻译可能不太完整准确）
Stud Mycol. 2024 Dec;109:487-594. doi: 10.3114/sim.2024.109.08. Epub 2024 Oct 23.
7
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.对早期预后不良或晚期霍奇金淋巴瘤患者，比较包括强化BEACOPP方案的一线化疗与包括ABVD方案的化疗。
Cochrane Database Syst Rev. 2017 May 25;5(5):CD007941. doi: 10.1002/14651858.CD007941.pub3.
8
Prognostic Impact of Quantitative Changes Between Baseline and Interim 18 F-FDG PET/CT in Pediatric Classic Hodgkin Lymphoma.基线与中期18F-FDG PET/CT定量变化对儿童经典型霍奇金淋巴瘤的预后影响
Clin Nucl Med. 2025 Jul 1;50(7):e407-e416. doi: 10.1097/RLU.0000000000005874. Epub 2025 Mar 31.
9
Answer to the letter to the editor of Z. Feng, et al. concerning "How much does an MRI change over a period of up to 2 years in patients with chronic low back pain? Is a repeated MRI really necessary in the follow-up of patients with chronic low back pain?" by Tomé-Bermejo F, et al. (Eur spine J [2024]; https://doi.org/10.1007/s00586-024-08416-1).对Z. Feng等人致编辑信的回复，该信涉及Tomé-Bermejo F等人的文章《慢性腰痛患者的MRI在长达2年的时间里变化有多大？慢性腰痛患者随访中重复进行MRI真的有必要吗？》（《欧洲脊柱杂志》[2024]；https://doi.org/10.1007/s00586-024-08416-1）
Eur Spine J. 2025 Aug 18. doi: 10.1007/s00586-025-09278-x.
10
Survival and Clinicopathological Significance of CD47 in Human Solid Tumors: An Updated Systematic Reviews and Meta-Analysis.CD47在人类实体瘤中的生存情况及临床病理意义：一项更新的系统评价与Meta分析
Cancer Rep (Hoboken). 2025 Aug;8(8):e70296. doi: 10.1002/cnr2.70296.
本文引用的文献
1
Does CD47 expression have prognostic significance in classical Hodgkin lymphoma?CD47表达在经典型霍奇金淋巴瘤中是否具有预后意义？
Turk J Med Sci. 2024 Dec 30;55(1):203-208. doi: 10.55730/1300-0144.5958. eCollection 2025.
2
Checkpoint CD47 expression in classical Hodgkin lymphoma.检查经典型霍奇金淋巴瘤中的 CD47 表达。
Br J Haematol. 2022 Jun;197(5):580-589. doi: 10.1111/bjh.18137. Epub 2022 Mar 17.
3
Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma.血浆胸腺和活化调节趋化因子（TARC）在经典型霍奇金淋巴瘤中的生物学特性及临床适用性
Cancers (Basel). 2021 Feb 20;13(4):884. doi: 10.3390/cancers13040884.
4
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study.霍奇金淋巴瘤患者血清 TARC、MDC、IL-10 和可溶性 CD163 水平：SWOG S0816 相关性研究。
Blood. 2019 Apr 18;133(16):1762-1765. doi: 10.1182/blood-2018-08-870915. Epub 2019 Feb 5.
5
Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC.用于评估经典型霍奇金淋巴瘤治疗反应的生物标志物：可溶性半乳糖凝集素-1、可溶性CD163和可溶性CD30与胸腺和活化调节趋化因子的比较
Br J Haematol. 2016 Dec;175(5):868-875. doi: 10.1111/bjh.14317. Epub 2016 Sep 9.
Zotero 插件